Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 11.60% and Operating profit at -0.94% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 14.45% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 11.60% and Operating profit at -0.94% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
4
With ROE of 8.50%, it has a very expensive valuation with a 1.88 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.38%
0%
-8.38%
6 Months
-18.76%
0%
-18.76%
1 Year
-15.92%
0%
-15.92%
2 Years
-32.11%
0%
-32.11%
3 Years
-52.46%
0%
-52.46%
4 Years
-35.78%
0%
-35.78%
5 Years
-63.05%
0%
-63.05%
LBX Pharmacy Chain JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.60%
EBIT Growth (5y)
-0.94%
EBIT to Interest (avg)
7.30
Debt to EBITDA (avg)
2.29
Net Debt to Equity (avg)
0.89
Sales to Capital Employed (avg)
1.50
Tax Ratio
26.26%
Dividend Payout Ratio
59.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.47%
ROE (avg)
14.45%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
1.88
EV to EBIT
21.58
EV to EBITDA
7.29
EV to Capital Employed
1.48
EV to Sales
0.83
PEG Ratio
NA
Dividend Yield
1.89%
ROCE (Latest)
6.85%
ROE (Latest)
8.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
5,321.90
5,380.50
-1.09%
Operating Profit (PBDIT) excl Other Income
652.90
700.20
-6.76%
Interest
33.00
47.70
-30.82%
Exceptional Items
1.50
0.00
Consolidate Net Profit
188.20
221.60
-15.07%
Operating Profit Margin (Excl OI)
46.80%
56.30%
-0.95%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -1.09% vs 0.49% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -15.07% vs -19.36% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
22,276.70
22,358.50
-0.37%
Operating Profit (PBDIT) excl Other Income
2,776.10
2,902.60
-4.36%
Interest
191.90
199.90
-4.00%
Exceptional Items
-103.60
4.10
-2,626.83%
Consolidate Net Profit
685.10
1,123.60
-39.03%
Operating Profit Margin (Excl OI)
50.20%
64.30%
-1.41%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.37% vs 11.12% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -39.03% vs 15.10% in Dec 2023
About LBX Pharmacy Chain JSC 
LBX Pharmacy Chain JSC
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






